GEIS Group GEIS Group

ACCESS YOUR ACCOUNT

User
Password
Remember me
  • Forgot your password?
  • Forgot User?
  • Español
  • English

Main Menu

  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guidelines
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2025 Symposium
    • 2024 Symposium
    • 2023 Symposium
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to the National Registry
    • Reports
  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guidelines
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2025 Symposium
    • 2024 Symposium
    • 2023 Symposium
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to the National Registry
    • Reports
que-son-sarcomas
  1. Home
  2. What are sarcomas?
  3. Ewing sarcomas

Ewing sarcoma arises

EwingEwing sarcoma is a rare kind of bone cancer that affects children or very young people and that can be cured even when it has spread to other organs. Its cause remains unknown. It is named after James Stephen Ewing (1886 – 1943), the American pathologist that described it for the first time, and marked it apart from similar tumors.

Cancer frequently affects the skeleton. However, only a small portion of malignant tumors on the bones are sarcomas. Most of them are metastasis or common cancer ramifications not related to sarcomas, as breast, prostate or lung cancer. For example, a woman could develop breast cancer and some of the malignant cells of that tumor might peel off, get into the circulatory system and through it, arrive to some place of the skeleton, where the cells would nest and multiply, and finally create secondary tumors. Certainly, that woman would have bone cancer, but not a sarcoma. If a pathologist would examine a sample of the metastasis with the help of a microscope, he would discover that the tumors were composed by cells similar to those present in the mammary gland.

EwingInstead, Ewing sarcoma arrises from the bone itself, and if analyzed under a microscope, it can be proved that it is composed of unique cells that look different to any other cancers and to most of the rest of sarcomas. There are, however, some other malignant tumors of the skeleton with which it might be mistaken. It is important to identify the difference, because Ewing Sarcoma has a very specific and effective treatment. Sometimes the precise diagnosis of this tumor requires very advanced techniques, as the analysis of the genetic material looking for concise alterations of the chromosomes, a trait only present on this disease. That is why patients with Ewing Sarcoma should be checked by true specialists on sarcomas since the very moment of diagnosis. Multidisciplinary teams used to deal with a significant number of this rare condition usually have amongst their number super specialized pathologists able to make the diagnosis with pinpoint accuracy.

  • WHAT ARE SARCOMAS?
  • Soft Tissue Sarcomas
  • Skeletal sarcomas
  • Ewing sarcoma
  • Gastrointestinal Stromal Tumor (GIST)
  • Pediatric Sarcoma
  • Treatments
  • Surgery
  • Chemotherapy
  • Radiotherapy

Grupo GEIS

ABOUT GEIS

  • About us
  • What are sarcomas
  • Patients
  • Request GEIS scientific endorsement

INFORMATION

  • GEIS Symposiums
  • Schedule
  • News
  • Employment opportunities
 

This site contents are not a valid substitute for medical diagnosis, prognosis or treatment given by a doctor. GEIS must insist that the decisions related to sarcoma patients must always be sanctioned by a specialist familiar to this condition after personally meeting the subject. This website operates under its User Terms and Conditions.

Copyright © 2025 GEIS Group. All Rights Reserved. Diseño Comuniland.
  • Legal disclaimer
  • Privacy policy
  • Sitemap
  • Cookies
  • Contact us